Navigation Links
Par Pharmaceutical Reports Third-Quarter 2007 Results
Date:12/20/2007

arter of 2006.

In addition, Par's reported, or GAAP, results for the first nine months of 2007, included a $20.0 million gain on the sale to Optimer Pharmaceutical, Inc. of marketing rights to the investigational drug Difimicin, a $1.4 million investment gain on the sale of shares of Optimer common stock, and net settlement gains of $0.6 million, tempered by a $6.0 million loss on investment, a $3.0 million license fee paid to Immtech Pharmaceuticals for commercialization rights to the developmental drug pafuramidine and $1.6 million of severance costs. Adjusting for these items, net income for the nine months ended September 29, 2007 was $48.5 million, or $1.39 per diluted share. By comparison, reported GAAP results for the nine months ended September 30, 2006 also included a write-off of approximately $10.0 million of accounts receivable relating to invalid customer deductions, the collection of which the Company determined that it would no longer pursue, severance costs, and net investment and arbitration settlement losses. Adjusting for these items, net income for the first nine months of 2006 was $14.6 million, or $0.42 per diluted share (see reconciliation between reported (GAAP) and adjusted net income at the end of this press release).

Third-Quarter Review

For the third quarter ended September 29, 2007, total revenues increased 22.2 percent compared with the same period in 2006 due primarily to new product introductions. The third quarter launch of three additional strengths of metoprolol succinate ER (50mg, 100mg, and 200mg), coupled with the fourth quarter 2006 launch of the 25mg strength, drove $71.7 million of sales and corresponding year-over-year gains. Par markets metoprolol in the U.S. through supply and distribution agreements with AstraZeneca Plc. In addition, the first quarter 2007 introductions of propranolol HCl extended release (ER) capsules and ranitidine HCl syrup benefited the third-quarter by $12.1 million and $4.4 mill
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 ... training and compliance solutions for the healthcare market, ... The Arc to offer 10 complimentary courses relating ... provide public safety professionals with additional resources to ... Safety professionals are often the first responders to ...
(Date:6/2/2015)... 02, 2015 Recent findings from the ... while there has been a reduction in conventional cigarette ... waterpipe vapor (hookah) usage has doubled among today’s teens ... Russell Gombosi believes the national trend is consistent with ... 15 to 20 years to fully determine the long-term ...
(Date:6/2/2015)... Glidewell Laboratories, industry-leading provider of ... the new issue of Chairside® magazine, its restorative-dentistry-focused ... The digital edition of the latest issue, Volume ... of the dental laboratory’s magazine, can be viewed ... by visiting http://www.chairsidemagazine.com . , In the ...
(Date:6/2/2015)... 02, 2015 Residents of Monarch Landing ... swim, take a fitness class, do yoga, play volleyball, ... In preparation for the Alzheimer’s Association’s Walk to End ... will take part in a challenge to exercise for ... Landing’s management company. , While the walk will raise ...
Breaking Medicine News(10 mins):Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3
... intimate partners spent 42 percent more on health care per ... more than 3,000 women. , And the costs don,t end ... suffered physical abuse five or more years earlier still spent ... who were never abused. , "Along with all the physical ...
... Services, Inc. announced today that it has provided ... Hospital in Mountain View, California. The five-year tax-exempt ... Siemens Medical Solutions equipment which will be deployed ... http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )"For more than 40 years, ...
... Kiley Carlson of Sioux City, IA will travel to ... 2009 to meet with congressional leaders and gain their ... toward a cure for epilepsy.Carlson, 16, is one of ... Kids Speak Up! , a national program coordinated ...
... 23 Fujirebio Diagnostics, Inc., the premier cancer ... biomarker assays, today announced the appointment of Grady ... Barnes comes to Fujirebio Diagnostics with 25 years ... positions at Abbott and Meridian Bioscience, most recently ...
... demonstrated how a single-celled organism, living freely in the ... transmission to animals and humans. , Salmonella ... food type, causing diarrhoea, abdominal pain and fever. ... also cause typhoid fever has evolved unique mechanisms ...
... access to largest portfolio of clinical laboratory ... Healthcare ( www.siemens.com/diagnostics ) and Sysmex Corporation ... of a five-year contract renewal for a ... Under the agreement, clinical laboratory customers around ...
Cached Medicine News:Health News:Physical abuse raises women's health costs over 40 percent 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 3Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer 2Health News:Study shows how Salmonella survives in environment 2Health News:Siemens and Sysmex Renew Global Agreement 2Health News:Siemens and Sysmex Renew Global Agreement 3
(Date:6/2/2015)... SUNNYVALE, Calif. , June 2, 2015  Accuray ... management team is scheduled to present at the Goldman ... Rancho Palos Verdes, California on Wednesday, June ... live webcast of the presentation will be available on ... http://www.accuray.com/investors .  The webcast replay of the presentation ...
(Date:6/2/2015)...  Ovatemp proudly launches the only women,s health platform that ... life cycle, from puberty through menopause. With Ovatemp, women ... and connected Ovatemp app to naturally improve their fertile ... pregnancy altogether. The ONDO can now be purchased at ... be downloaded from the App Store . ...
(Date:6/2/2015)... 2, 2015 Accera, Inc. today ... as president and chief executive officer. ... industry as a physician, company executive and investment professional. ... manager with London -based Inventages, one ... private equity firms. In this position he managed global ...
Breaking Medicine Technology:Techstars-backed Startup Ovatemp Launches the Only Complete, Personalized Fertility Management Platform for Women 2Accera Appoints Charles Stacey, M.D., as President and CEO 2Accera Appoints Charles Stacey, M.D., as President and CEO 3Accera Appoints Charles Stacey, M.D., as President and CEO 4
... 2012  Continuing to meet the complex needs of ... ISO13485-certified, FDA compliant contract manufacturing and services company, ... compliant storage and order fulfillment services for their ... Telcare,s FDA and HIPAA-compliant solution, Telcare BGM, ...
... Grifols (MCE:GRF, MCE:GRF.P and NASDAQ: GRFS ... a pioneer in the research and development of therapeutic ... development, has acquired 51% of the equity of Zaragoza-based ... and the future of the company. ...
Cached Medicine Technology:Cogmedix Provides Medical Device Storage and Order Fulfillment Services for Telcare Medical Supply 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8
TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
... Portable - Battery Powered (6 size ... Unit conversion (g, ct, oz, ozt, GN, ... Piece Counting and Percent Measure functions, Auto ... operation. Optional AC adapter may be ordered ...
... speed, stability and durability. Back-lighted Display. ... multiple units of measure, piece counting ... and GLP/GMP/ISO output including date and ... calibration with external weights only (selectable ...
60 month warranty, constructed entirely of aluminum alloy, allows the selection of 11 units of measure....
Medicine Products: